Neisseria meningitidis

Common Name(s)

Neisseria meningitidis

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neisseria meningitidis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neisseria meningitidis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Neisseria meningitidis" returned 785 free, full-text research articles on human participants. First 3 results:

Role of transition metal exporters in virulence: the example of Neisseria meningitidis.
 

Author(s): Cyril Guilhen, Muhamed-Kheir Taha, Frédéric J Veyrier

Journal:

 

Transition metals such as iron, manganese, and zinc are essential micronutrients for bacteria. However, at high concentration, they can generate non-functional proteins or toxic compounds. Metal metabolism is therefore regulated to prevent shortage or overload, both of which can impair ...

Last Updated: 6 Jan 2014

Go To URL
Neisseria meningitidis NalP cleaves human complement C3, facilitating degradation of C3b and survival in human serum.
 

Author(s): Elena Del Tordello, Irene Vacca, Sanjay Ram, Rino Rappuoli, Davide Serruto

Journal: Proc. Natl. Acad. Sci. U.S.A.. 2014 Jan;111(1):427-32.

 

The complement system is a crucial component of the innate immune response against invading bacterial pathogens. The human pathogen Neisseria meningitidis (Nm) is known to possess several mechanisms to evade the complement system, including binding to complement inhibitors. In this ...

Last Updated: 8 Jan 2014

Go To URL
Three outbreak-causing Neisseria meningitidis serogroup C clones, Brazil(1.).
 

Author(s): David E Barroso, Terezinha M P P Castiñeiras, Fernanda S Freitas, Jane W Marsh, Mary G Krauland, Mary M Tulenko, Érica L Fonseca, Ana C P Vicente, Maria C Rebelo, Elaine O Cerqueira, Adriano C Xavier, Ana P C M Cardozo, Simone E M da Silva, Lee H Harrison

Journal: Emerging Infect. Dis.. 2013 Nov;19(11):1847-50.

 

During 2003-2012, 8 clusters of meningococcal disease were identified in Rio de Janeiro State, Brazil, all caused by serogroup C Neisseria meningitidis. The isolates were assigned to 3 clonal complexes (cc): cc11, cc32, and cc103. These hyperinvasive disease lineages were associated ...

Last Updated: 15 Nov 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Neisseria meningitidis" returned 23 free, full-text review articles on human participants. First 3 results:

Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease.
 

Author(s): Lisa K McNeil, Robert J Zagursky, Shuo L Lin, Ellen Murphy, Gary W Zlotnick, Susan K Hoiseth, Kathrin U Jansen, Annaliesa S Anderson

Journal: Microbiol. Mol. Biol. Rev.. 2013 Jun;77(2):234-52.

 

Neisseria meningitidis is a Gram-negative microorganism that exists exclusively in humans and can cause devastating invasive disease. Although capsular polysaccharide-based vaccines against serogroups A, C, Y, and W135 are widely available, the pathway to a broadly protective vaccine ...

Last Updated: 23 May 2013

Go To URL
Automated extraction of typing information for bacterial pathogens from whole genome sequence data: Neisseria meningitidis as an exemplar.
 

Author(s): K A Jolley, M C Maiden

Journal:

 

Whole genome sequence (WGS) data are increasingly used to characterise bacterial pathogens. These data provide detailed information on the genotypes and likely phenotypes of aetiological agents, enabling the relationships of samples from potential disease outbreaks to be established ...

Last Updated: 1 Feb 2013

Go To URL
Advances with vaccination against Neisseria meningitidis.
 

Author(s): Ray Borrow

Journal: Trop. Med. Int. Health. 2012 Dec;17(12):1478-91.

 

In the last decade, meningococcal serogroup C conjugate vaccination programs have been demonstrated to be hugely successful with a truly impressive public health impact. In sub-Saharan Africa, with the implementation of an affordable serogroup A conjugate vaccine, it is hoped that ...

Last Updated: 16 Dec 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Last Updated: 14 Jul 2014

Go to URL